Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

August 2, 2018

Hologic appoints Oberton as CFO as McMahon leaves for Calif. firm

Courtesy | Hologic Karleen Oberton

Marlborough medical device company Hologic has appointed company veteran Karleen Oberton to chief financial officer to replace Bob McMahon, who is leaving the company for the same post of a California medical device firm. 

Oberton, previously the company’s chief accounting officer, officially began in her new post Wednesday. In a statement, CEO Steve MacMillan said Oberton has a deep knowledge of the business after more than 12 years with the company. 

“She has been instrumental in our efforts both to drive profitable growth, and to strengthen our balance sheet and cash flows,” MacMillan said. 

Oberton first came aboard as a corporate controller in 2006 and was promoted to chief accounting officer in 2005, where she was responsible for the global finance organization, including controllership functions, financial planning and analysis, and shared services, according to the company.

Last year, Oberton was appointed to the company's new global leadership team. 

Prior to joining Hologic, Oberton, an 18-year certified public accountant, was a senior corporate controller of Waltham-based biotech Immunogen.

Before joining the in-house biotech finance world, she was senior audit manager at global accounting firm Ernst & Young’s life science practice and at Arthur Anderson’s high technology practice.

The announcement of Oberton’s promotion and McMahon’s departure was made simultaneous to the company’s release of its third-quarter earnings and announced acquisition of Arizona-based Faxitron Bioptics for $85 million. 

McMahon left to join the finance team at California laboratory instrument manufacturer Agilent. He joins first as senior vice president starting Friday and will become CFO on Sept. 1, according to Agilent.

Agilent is a larger company than Hologic, with nearly $4.5 billion in revenue in 2017 compared to Hologic’s $3.06 billion. As of Thursday morning, Agilent was worth almost twice with a value of $20.7 billion compared to Hologic’s $11.4 billion.

Sign up for Enews

WBJ Web Partners

0 Comments

Order a PDF